Treatment of intraocular pressure elevation after photorefractive keratectomy

Zoltán Zsolt Nagy, Antal Szabó, Ronald R. Krueger, I. Süveges

Research output: Contribution to journalArticle

12 Citations (Scopus)

Abstract

Purpose: To study the effect of timolol maleate, dorzolamide, or a combination of both in post photorefractive keratectomy (PRK) eyes with an elevated intraocular pressure (IOP) after topical steroid administration. Setting: Refractive Surgery Outpatient Department, 1st Department of Ophthalmology, Semmelweis University, Budapest, Hungary. Methods: Forty-five patients with elevated IOP were randomly enrolled in 3 groups: Group 1 received timolol maleate 0.5% twice a day; Group 2 received timolol maleate 0.5% twice a day and dorzolamide 2% 3 times a day; and Group 3 received only topical dorzolamide 2% 3 times a day. Intraocular pressure was measured 3 days and 1,3, and 6 weeks after the antiglaucoma medication was started. Results: The mean preoperative IOP was 15.25 mm Hg ± 1.28 (SD). Following administration of topical fluorometholone, the IOP increased a mean of 27.39 ± 2.88 mm Hg. Six weeks after the antiglaucoma therapy was started, the mean IOP reduction was 6.6 mm Hg in Group 1, 8.86 mm Hg in Group 2, and 4.64 mm Hg in Group 3. Conclusions: A combination therapy of timolol 0.5% and dorzolamide 2% was most effective in treating secondary IOP elevation after PRK. Dorzolamide alone did not adequately control secondary post-PRK IOP elevation.

Original languageEnglish
Pages (from-to)1018-1024
Number of pages7
JournalJournal of Cataract and Refractive Surgery
Volume27
Issue number7
DOIs
Publication statusPublished - 2001

Fingerprint

dorzolamide
Photorefractive Keratectomy
Intraocular Pressure
Timolol
Topical Administration
Therapeutics
Fluorometholone
Refractive Surgical Procedures
Hungary
Ophthalmology
Outpatients
Steroids

ASJC Scopus subject areas

  • Ophthalmology

Cite this

Treatment of intraocular pressure elevation after photorefractive keratectomy. / Nagy, Zoltán Zsolt; Szabó, Antal; Krueger, Ronald R.; Süveges, I.

In: Journal of Cataract and Refractive Surgery, Vol. 27, No. 7, 2001, p. 1018-1024.

Research output: Contribution to journalArticle

Nagy, Zoltán Zsolt ; Szabó, Antal ; Krueger, Ronald R. ; Süveges, I. / Treatment of intraocular pressure elevation after photorefractive keratectomy. In: Journal of Cataract and Refractive Surgery. 2001 ; Vol. 27, No. 7. pp. 1018-1024.
@article{93ff5c9939e941e5aec722ec944d574a,
title = "Treatment of intraocular pressure elevation after photorefractive keratectomy",
abstract = "Purpose: To study the effect of timolol maleate, dorzolamide, or a combination of both in post photorefractive keratectomy (PRK) eyes with an elevated intraocular pressure (IOP) after topical steroid administration. Setting: Refractive Surgery Outpatient Department, 1st Department of Ophthalmology, Semmelweis University, Budapest, Hungary. Methods: Forty-five patients with elevated IOP were randomly enrolled in 3 groups: Group 1 received timolol maleate 0.5{\%} twice a day; Group 2 received timolol maleate 0.5{\%} twice a day and dorzolamide 2{\%} 3 times a day; and Group 3 received only topical dorzolamide 2{\%} 3 times a day. Intraocular pressure was measured 3 days and 1,3, and 6 weeks after the antiglaucoma medication was started. Results: The mean preoperative IOP was 15.25 mm Hg ± 1.28 (SD). Following administration of topical fluorometholone, the IOP increased a mean of 27.39 ± 2.88 mm Hg. Six weeks after the antiglaucoma therapy was started, the mean IOP reduction was 6.6 mm Hg in Group 1, 8.86 mm Hg in Group 2, and 4.64 mm Hg in Group 3. Conclusions: A combination therapy of timolol 0.5{\%} and dorzolamide 2{\%} was most effective in treating secondary IOP elevation after PRK. Dorzolamide alone did not adequately control secondary post-PRK IOP elevation.",
author = "Nagy, {Zolt{\'a}n Zsolt} and Antal Szab{\'o} and Krueger, {Ronald R.} and I. S{\"u}veges",
year = "2001",
doi = "10.1016/S0886-3350(01)00889-6",
language = "English",
volume = "27",
pages = "1018--1024",
journal = "Journal of Cataract and Refractive Surgery",
issn = "0886-3350",
publisher = "Elsevier Inc.",
number = "7",

}

TY - JOUR

T1 - Treatment of intraocular pressure elevation after photorefractive keratectomy

AU - Nagy, Zoltán Zsolt

AU - Szabó, Antal

AU - Krueger, Ronald R.

AU - Süveges, I.

PY - 2001

Y1 - 2001

N2 - Purpose: To study the effect of timolol maleate, dorzolamide, or a combination of both in post photorefractive keratectomy (PRK) eyes with an elevated intraocular pressure (IOP) after topical steroid administration. Setting: Refractive Surgery Outpatient Department, 1st Department of Ophthalmology, Semmelweis University, Budapest, Hungary. Methods: Forty-five patients with elevated IOP were randomly enrolled in 3 groups: Group 1 received timolol maleate 0.5% twice a day; Group 2 received timolol maleate 0.5% twice a day and dorzolamide 2% 3 times a day; and Group 3 received only topical dorzolamide 2% 3 times a day. Intraocular pressure was measured 3 days and 1,3, and 6 weeks after the antiglaucoma medication was started. Results: The mean preoperative IOP was 15.25 mm Hg ± 1.28 (SD). Following administration of topical fluorometholone, the IOP increased a mean of 27.39 ± 2.88 mm Hg. Six weeks after the antiglaucoma therapy was started, the mean IOP reduction was 6.6 mm Hg in Group 1, 8.86 mm Hg in Group 2, and 4.64 mm Hg in Group 3. Conclusions: A combination therapy of timolol 0.5% and dorzolamide 2% was most effective in treating secondary IOP elevation after PRK. Dorzolamide alone did not adequately control secondary post-PRK IOP elevation.

AB - Purpose: To study the effect of timolol maleate, dorzolamide, or a combination of both in post photorefractive keratectomy (PRK) eyes with an elevated intraocular pressure (IOP) after topical steroid administration. Setting: Refractive Surgery Outpatient Department, 1st Department of Ophthalmology, Semmelweis University, Budapest, Hungary. Methods: Forty-five patients with elevated IOP were randomly enrolled in 3 groups: Group 1 received timolol maleate 0.5% twice a day; Group 2 received timolol maleate 0.5% twice a day and dorzolamide 2% 3 times a day; and Group 3 received only topical dorzolamide 2% 3 times a day. Intraocular pressure was measured 3 days and 1,3, and 6 weeks after the antiglaucoma medication was started. Results: The mean preoperative IOP was 15.25 mm Hg ± 1.28 (SD). Following administration of topical fluorometholone, the IOP increased a mean of 27.39 ± 2.88 mm Hg. Six weeks after the antiglaucoma therapy was started, the mean IOP reduction was 6.6 mm Hg in Group 1, 8.86 mm Hg in Group 2, and 4.64 mm Hg in Group 3. Conclusions: A combination therapy of timolol 0.5% and dorzolamide 2% was most effective in treating secondary IOP elevation after PRK. Dorzolamide alone did not adequately control secondary post-PRK IOP elevation.

UR - http://www.scopus.com/inward/record.url?scp=0034899719&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0034899719&partnerID=8YFLogxK

U2 - 10.1016/S0886-3350(01)00889-6

DO - 10.1016/S0886-3350(01)00889-6

M3 - Article

VL - 27

SP - 1018

EP - 1024

JO - Journal of Cataract and Refractive Surgery

JF - Journal of Cataract and Refractive Surgery

SN - 0886-3350

IS - 7

ER -